How Much Omega-3 Should You Take for Dry Eyes?

Most clinical trials that found dry-eye improvements used between 1,000 and 3,000 mg of combined EPA and DHA per day, with emerging evidence pointing toward the higher end of that range and a heavier share of EPA as the more effective approach. That said, the single largest and most rigorous trial ever conducted on this question found no benefit at all from 3,000 mg daily, which means the dosing conversation is more nuanced than supplement labels suggest. What your eyes actually need from omega-3 depends on factors researchers are still sorting out, including your baseline omega-3 status and the specific form of the supplement you choose.

The Evidence Is Genuinely Split

Before talking numbers, you should know that the research on omega-3 and dry eyes does not point cleanly in one direction. Dozens of smaller trials have found real improvements in symptoms and clinical markers. A 2014 meta-analysis pooling randomized controlled trials reported that omega-3 supplementation significantly improved tear break-up time (a measure of tear film stability) and the Schirmer test (which measures tear volume).¹ A more recent 2023 systematic review and meta-analysis confirmed those findings and went further, showing that higher daily doses and longer supplementation periods were associated with bigger reductions in dry-eye symptom scores.²

Then there is the DREAM trial, published in the New England Journal of Medicine in 2018, which enrolled 535 people with moderate-to-severe dry eye and gave them either 3,000 mg of omega-3 (2,000 mg EPA plus 1,000 mg DHA) or an olive oil placebo for 12 months. The result was stark: symptom scores, corneal staining, tear break-up time, and Schirmer test results all improved in both groups, with no meaningful difference between omega-3 and placebo.³ An extension study that randomized the omega-3 group to either continue or stop supplementation for another 12 months found the same thing: stopping made no difference.⁴

The DREAM trial carries weight because of its size and rigor, but it also raised questions about whether olive oil is truly inert as a placebo, since olive oil itself contains oleic acid and polyphenols with some anti-inflammatory activity. Critics have also pointed out that the trial did not account for participants’ baseline omega-3 levels. These are fair objections that have fueled ongoing debate rather than settling the question. Where does that leave you? Probably in the position of someone who might benefit from trying omega-3 if other dry-eye treatments alone are not enough, but who should not expect guaranteed results.

Dose Ranges That Showed Benefits

Across the trials that did find positive outcomes, doses ranged widely. On the lower end, a 30-day trial using just 360 mg EPA and 240 mg DHA daily (a total of 600 mg) found that tear break-up time improved by about 71% in the treatment group compared to only 3% in placebo, with dry-eye symptom scores dropping by roughly a quarter.⁵ On the higher end, a trial using capsules delivering 600 mg EPA and 1,640 mg DHA daily (about 2,240 mg total) found significant improvements in tear stability and meibomian gland dysfunction scores at eight weeks.⁶

The 2023 meta-analysis found that when the daily omega-3 dose went up, symptom scores went down, with a statistically significant relationship between higher doses and greater symptom relief.² If you look at the cluster of positive trials, a reasonable working range is somewhere between 1,000 and 3,000 mg of combined EPA and DHA per day. Below that, you might see some improvement, but the evidence for larger benefits comes at higher doses. Most eye-care professionals who recommend omega-3 for dry eyes tend to suggest at least 2,000 mg total daily, though this is a clinical judgment call rather than a universally agreed guideline.

EPA Matters More Than You Might Think

Not all omega-3 supplements are the same, and the EPA-to-DHA ratio turns out to be relevant. The 2023 meta-analysis found that a higher percentage of EPA in the supplement was independently and significantly associated with greater reduction in dry-eye symptoms, separate from the effect of total dose.² EPA is the omega-3 fatty acid more directly involved in resolving inflammation, while DHA plays a larger structural role in cell membranes. Since inflammation on the ocular surface is a central driver of dry-eye disease, it makes sense that EPA content tracks with symptom improvement.

That said, DHA is not irrelevant. The high-DHA trial mentioned earlier (1,640 mg DHA with only 600 mg EPA) still found positive results, particularly for people with meibomian gland dysfunction, where the oil glands in the eyelids are clogged or underperforming.⁶ DHA also appears to help meibomian gland cells produce more lipid-rich secretions. Lab research shows that omega-3 fatty acids stimulate the accumulation of lipid vesicles in meibomian gland cells and can increase triglyceride content by roughly two-fold to nearly four-fold, which helps replenish the oily outer layer of the tear film that prevents tears from evaporating too fast.⁷ So both fatty acids contribute, but if you are choosing between formulations, a higher EPA share has the stronger evidence behind it for overall symptom relief.

How Long Before You Feel a Difference

One of the most common questions people have is how quickly omega-3 supplements start working for dry eyes. The answer depends on what you mean by “working.” One observational study reported measurable improvements in tear film quality and comfort within just three days of supplementation.⁸ That is encouraging, but most of the rigorous trial evidence shows meaningful clinical improvement emerging at the six-to-twelve-week mark. The trial using re-esterified omega-3 capsules found significant improvements in tear osmolarity by week six and additional gains in tear break-up time and symptom scores by week twelve.⁹

The 30-day trial using a lower dose also found significant results within a single month.⁵ But duration of supplementation also tracked with outcomes in the broader meta-analysis: longer treatment periods correlated with greater symptom improvement.² The takeaway is that you might notice some subtle changes within the first few weeks, but giving omega-3 a fair trial means sticking with it for at least three months. If there is no improvement by then, the supplement probably is not going to be your solution.

Your Baseline Omega-3 Level Might Predict Whether Supplements Help

One of the more interesting findings in recent research is that people with low omega-3 levels at baseline seem to get much more out of supplementation than people who already have adequate levels. The omega-3 index, measured through a blood test, reflects the percentage of EPA and DHA in red blood cell membranes. A study of dry-eye patients found that improvements in symptoms, tear osmolarity, tear break-up time, and tear production were significantly better in people with an omega-3 index below 4%, compared to those starting at higher levels.¹⁰ This could partly explain why some trials find robust benefits while others (like DREAM) do not: if a trial enrolls people who already consume plenty of fish or take omega-3 supplements, topping up their intake further might not move the needle.

The omega-3 index is not a routine test most doctors order, and it is not always covered by insurance. But if you have tried omega-3 supplements without success, or if you are curious whether you are a good candidate before committing, asking about the test is reasonable. People who eat fatty fish two or more times a week, or who already supplement, are less likely to have a very low index and may be less likely to see dramatic improvement.

Contact Lens Wearers and Post-LASIK Dryness

Dry eyes from contact lens wear are a distinct subtype, and the evidence here is actually more consistently positive than for dry eye in general. A randomized trial giving contact lens wearers omega-3 supplements found significant improvements in symptom scores, tear break-up time, and lens comfort, with symptom improvement in the omega-3 group nearly ten times larger than in the placebo group.¹¹ A separate trial specifically measuring contact lens discomfort found that 12 weeks of oral fish oil reduced discomfort scores roughly twice as much as placebo and also lowered inflammatory markers in tears.¹²

Post-LASIK dry eye is another common scenario. LASIK temporarily disrupts corneal nerves, often causing dry-eye symptoms for weeks to months afterward. A trial of omega-3 supplementation in LASIK patients found that at three months, the supplement group had significantly better tear production (about 6 mm more on the Schirmer test) and less conjunctival surface damage compared to controls. Roughly 43% of control-group eyes showed staining damage, versus only 14% in the omega-3 group.¹³ If you are planning LASIK and already deal with borderline dry eyes, starting omega-3 supplementation before the procedure is worth discussing with your surgeon.

Combining Omega-3 With Omega-6

Some formulations pair omega-3 with gamma-linolenic acid (GLA), an omega-6 fatty acid found in evening primrose oil and borage oil. This is not a random pairing. GLA converts to an anti-inflammatory compound in the body, and combining it with omega-3 shifts the overall fatty acid balance further away from pro-inflammatory pathways. A 24-week trial of combined omega-3 and omega-6 supplementation in patients with moderate-to-severe dry eye found that symptom scores improved significantly compared to placebo, and inflammatory markers on the ocular surface were reduced by about a third.¹⁴ That trial did not find improvements in tear production or tear stability, though, suggesting the benefit was more about reducing surface inflammation and symptom perception than changing tear quantity.

The omega-3/omega-6 combination is an adjunctive approach, meaning it works alongside other dry-eye treatments like artificial tears, warm compresses, or prescription anti-inflammatory drops. Both omega-3 and omega-6 have been described as useful adjunctive supplements for dry-eye patients, particularly when inflammation plays a central role.¹⁵ No supplement replaces those treatments; the question is whether adding omega-3 (with or without omega-6) to your existing routine provides an extra layer of benefit.

Supplement Form and Bioavailability

Omega-3 supplements come in several chemical forms, and this turns out to matter. The most common over-the-counter form is ethyl ester, which is cheaper to produce but is absorbed less efficiently than the triglyceride or re-esterified triglyceride forms. The trial that used a re-esterified triglyceride formulation found substantial improvements: symptom scores dropped by 17 points in the omega-3 group versus 5 points in controls, and tear osmolarity (a measure of how “salty” or dehydrated tears are) fell significantly by week six, with further improvement by week twelve.⁹ This does not prove the re-esterified form is superior for dry eyes specifically, because no trial has directly compared formulations head-to-head in dry-eye patients. But the bioavailability difference is well-established in general omega-3 research: triglyceride and re-esterified forms are absorbed more completely, which means you may need a lower stated dose to actually get the same blood levels.

When you read a supplement label, check whether the dose listed is total fish oil or the actual EPA+DHA content. A capsule labeled “1,000 mg fish oil” might contain only 300 mg of EPA and DHA combined. To reach the 2,000-3,000 mg range of EPA+DHA used in most trials, you might need multiple capsules or a concentrated formulation. This arithmetic mismatch trips up a lot of people who think they are taking a therapeutic dose but are actually getting a fraction of one.

Safety at These Doses

The most common side effects of omega-3 supplements are gastrointestinal: fishy burps, mild nausea, or loose stools. These tend to improve if you take capsules with a meal or switch to enteric-coated versions. A persistent concern has been whether omega-3 increases bleeding risk, particularly at higher doses. A systematic review and meta-analysis of randomized trials found no overall increase in bleeding events among people taking omega-3 compared to those who did not. High-dose purified EPA was associated with a roughly 50% higher relative risk of any bleeding event, but the absolute increase was very small, translating to one additional bleeding event for every 166 people treated.¹⁶ At the doses used for dry eyes (typically under 3,000 mg), the bleeding concern is minimal for most people, but it is worth mentioning to your doctor if you are on blood-thinning medication.

Mercury contamination in fish oil is another common worry. Testing of commercially available fish oil brands has found mercury levels ranging from undetectable to negligible, similar to the trace concentrations normally present in human blood.¹⁷ The distillation process used to make fish oil concentrates removes most heavy metals, so this is one area where supplements actually have an advantage over eating the whole fish.

Plant-Based Omega-3 and Dry Eyes

Flaxseed oil, chia seeds, and walnuts are rich in alpha-linolenic acid (ALA), the plant-based omega-3. Your body can convert ALA into EPA and DHA, but the conversion rate is inefficient, typically estimated at well under 10%. Almost all dry-eye trials have used marine-derived EPA and DHA, not plant-based ALA, so the evidence base for flaxseed oil as a dry-eye treatment is thin. If you follow a vegan diet, algae-based omega-3 supplements provide EPA and DHA directly (since that is where fish get their omega-3 in the first place) and sidestep the conversion bottleneck. No large dry-eye trial has specifically tested algae-derived supplements, but the active compounds are chemically identical to what fish oil delivers.

The anti-inflammatory mechanism behind omega-3’s effect on dry eyes has been described as the primary way these fatty acids help: they compete with pro-inflammatory omega-6 fatty acids for the same enzymatic pathways, shifting the balance toward less inflammation on the eye’s surface.¹⁵ Getting EPA and DHA in your system, however you do it, is the goal. The source matters less than the dose and composition that actually reaches your bloodstream.

Screen Users and Evaporative Dry Eye

If your dry eyes are driven primarily by long hours at a computer or phone, you fall into a category researchers have started paying specific attention to. Prolonged screen use reduces blink rate, which accelerates tear evaporation and stresses the meibomian glands. Research on visual display terminal (VDT) users has found that dietary omega-3 supplementation is effective for this group, and that the omega-3 index may help predict who will respond well to treatment.¹⁰ This is relevant because evaporative dry eye, where the problem is tear instability rather than low tear production, tends to be the more common form in younger, screen-heavy populations. The mechanism through which omega-3 affects meibomian gland lipid output is particularly relevant here, since it is the oily outer layer of the tear film that keeps tears from evaporating between blinks.

Omega-3 alone will not counteract the effects of staring at a screen for 10 hours. The supplement works best as one piece of a broader strategy that includes deliberate blinking breaks, proper screen ergonomics, and potentially warm compresses to keep the meibomian glands functioning. Thinking of omega-3 as one tool rather than a standalone solution is the most realistic framing the evidence supports.

1
PubMed Central. Omega-3 Essential Fatty Acids Therapy for Dry Eye Syndrome: A Meta-Analysis of Randomized Controlled Studies
2
PubMed Central. Efficacy of Omega-3 Intake in Managing Dry Eye Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
3
PubMed Central. n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease
4
PubMed Central. The Dry Eye Assessment and Management (DREAM) extension study – A randomized clinical trial of withdrawal of supplementation with omega-3 fatty acid in patients with dry eye disease
5
PubMed. Short-term consumption of oral omega-3 and dry eye syndrome
6
PubMed Central. Effects of dietary high dose DHA omega-3 supplement in dry eye with meibomian gland dysfunction
7
PubMed Central. Influence of omega 3 and 6 fatty acids on human meibomian gland epithelial cells
8
PubMed Central. Potential ocular health benefit of short-term omega-3 fatty acids supplementation on the ocular tear film: An observational study
9
PubMed Central. Effect of Oral Re-esterified Omega-3 Nutritional Supplementation on Dry Eyes
10
PubMed Central. Omega-3 fatty acids supplements for dry eye – Are they effective or ineffective?
11
PubMed. Oral omega-3 fatty acid treatment for dry eye in contact lens wearers
12
PubMed. Modulating Contact Lens Discomfort With Anti-Inflammatory Approaches: A Randomized Controlled Trial
13
PubMed. Oral Omega-3 Fatty Acid Supplementation for Laser In Situ Keratomileusis-Associated Dry Eye
14
PubMed. Long-term Supplementation With n-6 and n-3 PUFAs Improves Moderate-to-Severe Keratoconjunctivitis Sicca: A Randomized Double-Blind Clinical Trial
15
PubMed Central. Nutritional supplements for dry eye syndrome
16
PubMed Central. Bleeding Risk in Patients Receiving Omega‐3 Polyunsaturated Fatty Acids: A Systematic Review and Meta‐Analysis of Randomized Clinical Trials
17
Archives of Pathology & Laboratory Medicine. Measurement of mercury levels in concentrated over-the-counter fish oil preparations: is fish oil healthier than fish?